+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men



Imiquimod cream 2.5% and 3.75% applied once daily to treat external genital warts in men



Cutis 96(4): 277-282



We assess the safety and efficacy of imiquimod cream 3.75% and 2.5% in men with external genital warts (EGWs). Two multicenter, randomized, double-blind, placebo-controlled studies were conducted in a total of 447 (225 from study 1 and 222 from study 2) male patients (aged ≥12 years) with 2 to 30 EGWs and a total wart area of 150 mm2 or greater. Participants were randomized (2:2:1) to imiquimod cream 3.75% or 2.5% or placebo applied once daily until complete clearance or a maximum of 8 weeks (end of treatment [EOT]). There was an 8-week follow-up period (end of study [EOS]) for participants who did not achieve complete clearance by EOT. Participants who achieved complete clearance were observed for an additional 12 weeks. The primary efficacy end point was complete clearance rate. Safety assessments included visual assessment of local skin reactions, number and duration of required rest periods, adverse events (AEs), and clinical laboratory tests. Study results indicated that new imiquimod formulations are beneficial in treating EGWs in men.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 058048728

Download citation: RISBibTeXText

PMID: 26682290


Related references

Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day. Sexually Transmitted Diseases 28(4): 226-231, 2001

Imiquimod 3.75% cream applied daily to treat anogenital warts: combined results from women in two randomized, placebo-controlled studies. Infectious Diseases in Obstetrics and Gynecology 2011: 806105, 2011

Large genital ulcers in a patient with Behçet's disease associated with imiquimod cream treatment for external genital warts. Clinical and Experimental Dermatology 33(6): 783-784, 2008

The role of imiquimod 3.75% cream in the treatment of external genital warts. Skin Therapy Letter 17(4): 5-7, 2012

Treatment of external genital warts with 5% imiquimod cream during pregnancy: a case report. Bjog 111(12): 1475, 2004

Efficacy and safety of 5% imiquimod cream in external genital warts: a 6 month follow-up evaluation. Annales de Dermatologie et de Venereologie 132(11 Pt 1): 845-851, 2005

Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women. International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 76(2): 191-193, 2002

Treatment of external genital warts in men with imiquimod 2% in cream. A placebo-controlled, double-blind study. Journal of Infection 41(2): 148-151, 2000

Topical imiquimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sexually Transmitted Diseases 30(2): 124-128, 2003

Comparison of two vehicle-controlled trials of imiquimod 5 percent cream for the treatment of external genital warts. Journal of Dermatological Science 16(Suppl. 1): S210, 1998

Pharmacokinetics of daily self-application of imiquimod 3.75% cream in adult patients with external anogenital warts. Journal of Clinical Pharmacology 52(6): 828-836, 2012

Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. International Journal of Std & Aids 12(1): 22-28, 2001

Optimal frequency of imiquimod (aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis. Sexually Transmitted Diseases 35(4): 346-351, 2008

Imiquimod 5% cream is safe and effective in an open-label multicenter study in patients with external genital/perianal warts. International Journal of STD & AIDS 12(Suppl. 2): 126-127, 2001

Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrobial Agents and ChemoTherapy 42(4): 789-794, 1998